Next Article in Journal / Special Issue
Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility
Previous Article in Journal
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
Previous Article in Special Issue
Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma
 
 
Article

Article Versions Notes

Cancers 2019, 11(6), 786; https://doi.org/10.3390/cancers11060786
Action Date Notes Link
article xml file uploaded 7 June 2019 09:59 CEST Original file -
article xml uploaded. 7 June 2019 09:59 CEST Update https://www.mdpi.com/2072-6694/11/6/786/xml
article pdf uploaded. 7 June 2019 09:59 CEST Version of Record https://www.mdpi.com/2072-6694/11/6/786/pdf
article supplementary file uploaded. 7 June 2019 09:59 CEST - https://www.mdpi.com/2072-6694/11/6/786#supplementary
article html file updated 7 June 2019 10:00 CEST Original file -
article html file updated 5 July 2019 19:03 CEST Update -
article html file updated 5 July 2019 19:03 CEST Update -
article html file updated 21 October 2019 12:35 CEST Update -
article html file updated 12 February 2020 18:16 CET Update -
article html file updated 20 July 2022 15:55 CEST Update https://www.mdpi.com/2072-6694/11/6/786/html
Back to TopTop